Phase III: The Jeanne Hopkins Lucas Study CBCS Newsletter T hank you, Survivors! Over the past few years, many women, including yourself, have invited us into their home to learn about their breast cancer diagnosis and treatment. They’ve responded to mail or phone contact every nine months or so to provide updated medical record information. As breast cancer survivors, these remarkable women have shared important information with us that will hopefully help us to understand what types of breast cancer are occurring among different age groups and races, learn what types of treatments are being offered, and observe what outcomes those treatments are providing. We are very grateful for your participation in this effort. It’s time for another follow-up, so we’ll be calling you in the next few weeks (a short 10 to 15 minute call) to see how you are doing. We look forward to speaking with you again. In the meantime, we hope you enjoy this edition of the CBCS Newsletter. Submissions from participants are showcased in the “Survivor Diaries” section. Also included is a breast cancer survivorship article, which we hope will have meaning for you. As always, please feel free to contact us with any questions or concerns. Thank you again for being a part of this important research. Remember, we cannot do it without you! “Beauty, grace, strength, and persistence…” An epidemiologic population-based breast cancer research study at the University of North Carolina- Chapel Hill Lineberger Comprehensive Cancer Center funded through the University Cancer Research Fund, the Komen Foundation, and the National Cancer Institute Survivorship 2 Survivor Diaries 3 CBCS Spotlight: Sara Williams 4 INSIDE THIS ISSUE: Phone: 1-866-927-6920 or Email: [email protected]http://cbcs.web.unc.edu/ UNC-Chapel Hill LCCC-North 1700 MLK Blvd, Rm 332 CB # 7294 Chapel Hill, NC 27599-7294 Study Contact Information - 3000 - 2900 - 2800 - 2700 - 2600 - 2500 - 2400 - 2300 - 2200 - 2100 - 2000 - 1900 - 1800 - 1700 - 1600 - 1500 - 1400 - 1300 - 1200 - 1100 - 1000 - 900 - 800 - 700 - 600 - 500 - 400 - 300 - 200 - 100 - 0 Recruitment Complete! As of October 2013, 3000 women are enrolled. Our ginkgo sapling has grown into a beautiful, full-grown ginkgo tree. Many thanks for your participation!
4
Embed
- 2900 An epidemiologic T hank you, Survivors! Chapel Hill · T hank you, Survivors! Over the past few years, many women, including yourself, have ... Sara Williams What Sara Does:
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
P h a s e I I I : T h e J e a n n e H o p k i n s L u c a s S t u d y
CBCS Newsletter
T hank you, Survivors! Over the past few years, many
women, including yourself, have
invited us into their home to learn
about their breast cancer diagnosis
and treatment. They’ve responded
to mail or phone contact every nine
months or so to provide updated
medical record information. As
breast cancer survivors, these
remarkable women have
shared important information
with us that will hopefully
help us to understand what
types of breast cancer are
occurring among different
age groups and races, learn
what types of treatments are
being offered, and observe
what outcomes those
treatments are providing. We
are very grateful for your
participation in this effort.
It’s time for another follow-up, so
we’ll be calling you in the next few
weeks (a short 10 to 15 minute call)
to see how you are doing. We look
forward to speaking with you again. In the
meantime, we hope you enjoy this edition of the
CBCS Newsletter. Submissions from participants are
showcased in the “Survivor Diaries” section. Also included is
a breast cancer survivorship article, which we hope will have
meaning for you.
As always, please feel free to contact us with any questions
or concerns. Thank you again for being a part of this
important research. Remember, we cannot do it without you!
“Beauty, grace, strength,
and persistence…”
An epidemiologic population-based breast
cancer research study at the University of North Carolina-